Cytokinetics Inc Equity-NMS: CYTK

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Previous close :$40.25
Open :$39.43
Today's high :$42.37
Today's low :$39.11
52W low :$37.46
52W high :$75.71
EPS(TTM): :-5.26
Shares O/S :118.41 M
Market cap :4.8 B

Compare with Other Stocks

Stocks Price 1D PE Market Cap
Cytokinetics Inc $40.52 +0.55% - 4.80B

Frequently Asked Questions

What is the share price of Cytokinetics Inc today?

Cytokinetics Inc (CYTK) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About Cytokinetics Inc

Cytokinetics, Incorporated is a late-stage, specialty cardiovascular biopharmaceutical company focused on discovering, developing and commercializing muscle biology-directed drug candidates as potential treatments for debilitating diseases in which cardiac muscle performance is compromised. The Company is engaged in the commercialization of aficamten, a cardiac myosin inhibitor, and is being evaluated in additional clinical trials enrolling patients with obstructive and non-obstructive hypertrophic cardiomyopathy. The Company is also developing omecamtiv mecarbil, a cardiac myosin activator, in patients with heart failure with severely reduced ejection fraction (HFrEF); CK-586, a cardiac myosin inhibitor for the potential treatment of heart failure with preserved ejection fraction (HFpEF) and CK-089, a fast skeletal muscle troponin activator with potential therapeutic application to a specific type of muscular dystrophy and other conditions of impaired skeletal muscle function.